Epiq Class Action Settlement Efficiency

August 19th, 2022|Categories: Emerging-On-Demand-CLE, Featured On-Demand, Risk-On-Demand-CLE, Torts-On-Demand-CLE|Tags: , , , , , , , |

Epiq presents a CLE-eligible webinar Wait Wait ... Don't Settle! Essential elements of effective class action settlements. When it comes to complex class action litigation, once the hard work is done – litigation and settlement – more hard work begins – administering it.  But is the deal really ready? After years of arduous proceedings, discovery, motions, appeals, hearings, negotiations, and more, the scope and structure of your settlement has been drafted. Everyone is in agreement. The hard work of the courts, the attorneys, the legal teams, and the litigants is complete. Now it's time to administer the settlement. Send out notices. Cut the checks. Get people paid. Boom! Sit back and relax. Get a claims administrator to take it from there. But wait … you find out that the terms of the agreement, the promises made, the budget established, and the [...]

Sexual Abuse Litigation and Insurance Coverage

August 19th, 2022|Categories: Emerging Issues Webinars, Featured On-Demand, New Webinars, Tort Webinars|Tags: , , , , , , , , |

Insurance Coverage for Sexual Abuse Claims  Strategies | Response | Insurance Archeology CLE OnDemand Webinar Sexual abuse claims – such as those involving the Catholic Church and the Boy Scouts of America – have resulted in verdicts and settlements in the tens and hundreds of millions of dollars. The Catholic church alone has paid billions to resolve claims. Verdicts in cases involving adult victims are typically lower than those involving children and teens. A December 2021 $44 million verdict to a Texas woman who was raped at a Hilton Hotel in Houston could signal that juries may be more open to larger awards in such cases. While rapists and abusers face accountability under criminal law (and sometimes under civil law as well), businesses and institutions of all shapes and sizes are increasingly finding themselves confronting claims that [...]

The Trajectory of Remote eDiscovery Review in 2022

November 12th, 2021|Categories: Featured On-Demand, New Webinars, Tort Webinars|Tags: , , , , , , , |

Epiq presents a CLE-eligible webinar The Trajectory of Remote eDiscovery in 2022 Practical guidelines for planning the eDiscovery program for your firm or legal department based on the latest insights. Join legal industry analyst Ari Kaplan, Eric Crawley, Epiq’s managing director for global advanced solutions, Seth Eichenholtz, Director of eDiscovery at Mastercard, and Lora Ramsey, eDiscovery Manager at Walmart for a discussion about the current state of electronic discovery within corporate legal departments and the future of remote options in a post-pandemic environment. Kaplan will reveal – and the panel will discuss – findings from the Epiq-commissioned report based on the perspectives of 30 leading corporate legal eDiscovery professionals about the challenges, tactics, and best practices fueling change in this sector. Eighty-seven percent of the respondents reported that they handle some document review processes with support from [...]

Mass Tort Judicial Forum w/ Corodemus | April 23, 2018

January 10th, 2018|Categories: HB Risk Notes|Tags: , , , , , , , , |

We were proud to have worked with Judge Corodemus for 8 years! She truly is a highly regarded and intelligent leader who dedicates herself to bringing complex claims to resolution. Plus, she's alot of fun! Scroll down, peruse the agenda and list of speakers. We have phased live conferences out and no longer offer it as a service. Please visit our home page for a menu of all we do. Sponsors Special thanks to our friends at Drinker Biddle! HB's Recommended Readings State Court Jurisdiction in the 21st Century by Prof. Adam N. Steinman for the Pound Civil Justice Institute. Download it now. An Assessment of the Real World Implications of the New Jersey Supreme Court’s McCarrell Decision by William J. Beausoleil of Hughes Hubbard & Reed LLP. Read it now. Accutane Plaintiffs Overcome the “Super-Presumption” That FDA-Approved Warnings About Drugs are Adequate by Bruce D. Greenberg, Lite DePalma Greenberg, LLC. Read [...]

Go to Top